<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Antioxid Redox Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Antioxid. Redox Signal</journal-id>
<journal-id journal-id-type="publisher-id">ars</journal-id>
<journal-title-group>
<journal-title>Antioxidants &amp; Redox Signaling</journal-title>
</journal-title-group>
<issn pub-type="ppub">1523-0864</issn>
<issn pub-type="epub">1557-7716</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc.</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27758118</article-id>
<article-id pub-id-type="pmc">5346956</article-id>
<article-id pub-id-type="publisher-id">10.1089/ars.2016.6715</article-id>
<article-id pub-id-type="doi">10.1089/ars.2016.6715</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Forum Original Research Communication<break></break><italic>Redox Proteomics – Part II (D.A. Butterfield &amp; M. Perluigi, Eds.)</italic></subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Palmieri</surname>
<given-names>Erika M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menga</surname>
<given-names>Alessio</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lebrun</surname>
<given-names>Aurore</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3,</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hooper</surname>
<given-names>Douglas C.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3,</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butterfield</surname>
<given-names>D. Allan</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5,</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mazzone</surname>
<given-names>Massimiliano</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7,</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Castegna</surname>
<given-names>Alessandra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Department of Biosciences, Biotechnologies and Biopharmaceutics, <institution>University of Bari</institution>, Bari, <country>Italy</country>.</aff>
<aff id="aff2"><label><sup>2</sup></label>National Cancer Research Center, Istituto Tumori ‘Giovanni Paolo II,’ Bari, <country>Italy</country>.</aff>
<aff id="aff3"><label><sup>3</sup></label>Department of Cancer Biology, <institution>Thomas Jefferson University</institution>, Philadelphia, Pennsylvania.</aff>
<aff id="aff4"><label><sup>4</sup></label>Department of Neurological Surgery, <institution>Thomas Jefferson University</institution>, Philadelphia, Pennsylvania.</aff>
<aff id="aff5"><label><sup>5</sup></label>Department of Chemistry, <institution>University of Kentucky</institution>, Lexington, Kentucky.</aff>
<aff id="aff6"><label><sup>6</sup></label>Sanders-Brown Center on Aging, <institution>University of Kentucky</institution>, Lexington, Kentucky.</aff>
<aff id="aff7"><label><sup>7</sup></label>Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, <institution>University of Leuven</institution>, Leuven, <country>Belgium</country>.</aff>
<aff id="aff8"><label><sup>8</sup></label>Laboratory of Tumor Inflammation and Angiogenesis, Vesalius Research Center, VIB, Leuven, <country>Belgium</country>.</aff>
</contrib-group>
<author-notes>
<fn fn-type="equal" id="fn1">
<label>
<sup>*</sup>
</label>
<p>These authors contributed equally to this work.</p>
</fn>
<corresp>
<addr-line>Address correspondence to:</addr-line>
<addr-line>
<italic>Prof. Massimiliano Mazzone</italic>
</addr-line>
<addr-line>
<italic>Laboratory of Tumor Inflammation and Angiogenesis</italic>
</addr-line>
<addr-line>
<italic>Department of Oncology</italic>
</addr-line>
<addr-line>
<italic>VIB Vesalius Research Center</italic>
</addr-line>
<institution>
<italic>University of Leuven</italic>
</institution>
<addr-line>
<italic>Herestraat 49, box 912</italic>
</addr-line>
<addr-line>
<italic>Leuven B-3000</italic>
</addr-line>
<country>Belgium</country>
<break></break>
<italic>E-mail:</italic>
<email xlink:href="mailto:massimiliano.mazzone@vib-kuleuven.be">massimiliano.mazzone@vib-kuleuven.be</email>
</corresp>
<corresp>
<addr-line>
<italic>Prof. Alessandra Castegna</italic>
</addr-line>
<addr-line>
<italic>Department of Biosciences, Biotechnology and Biopharmaceutics</italic>
</addr-line>
<institution>
<italic>University of Bari</italic>
</institution>
<addr-line>
<italic>Via Orabona 7</italic>
</addr-line>
<addr-line>
<italic>Bari 70125</italic>
</addr-line>
<country>Italy</country>
<break></break>
<italic>E-mail:</italic>
<email xlink:href="mailto:alessandra.castegna@uniba.it">alessandra.castegna@uniba.it</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>10</day>
<month>3</month>
<year>2017</year>
<!--string-date: March 10, 2017-->
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>3</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>26</volume>
<issue>8</issue>
<fpage>351</fpage>
<lpage>363</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>3</month>
<year>2016</year>
<!--string-date: Date of first submission to ARS Central, March 31, 2016-->
</date>
<date date-type="rev-recd">
<day>23</day>
<month>9</month>
<year>2016</year>
<!--string-date: date of final revised submission, September 23, 2016-->
</date>
<date date-type="accepted">
<day>29</day>
<month>9</month>
<year>2016</year>
<!--string-date: date of acceptance, September 29, 2016-->
</date>
</history>
<permissions>
<copyright-statement>Copyright 2017, Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="ars.2016.6715.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p><bold><italic>Aims:</italic></bold> Microglial cells are brain-resident macrophages engaged in surveillance and maintained in a constant state of relative inactivity. However, their involvement in autoimmune diseases indicates that in pathological conditions microglia gain an inflammatory phenotype. The mechanisms underlying this change in the microglial phenotype are still unclear. Since metabolism is an important modulator of immune cell function, we focused our attention on glutamine synthetase (GS), a modulator of the response to lipopolysaccharide (LPS) activation in other cell types, which is expressed by microglia.</p>
<p><bold><italic>Results:</italic></bold> GS inhibition enhances release of inflammatory mediators of LPS-activated microglia <italic>in vitro</italic>, leading to perturbation of the redox balance and decreased viability of cocultured neurons. GS inhibition also decreases insulin-mediated glucose uptake in microglia. <italic>In vivo</italic>, microglia-specific GS ablation enhances expression of inflammatory markers upon LPS treatment. In the spinal cords from experimental autoimmune encephalomyelitis (EAE), GS expression levels and glutamine/glutamate ratios are reduced.</p>
<p><bold><italic>Innovation:</italic></bold> Recently, metabolism has been highlighted as mediator of immune cell function through the discovery of mechanisms that (behind these metabolic changes) modulate the inflammatory response. The present study shows for the first time a metabolic mechanism mediating microglial response to a proinflammatory stimulus, pointing to GS activity as a master modulator of immune cell function and thus unraveling a potential therapeutic target.</p>
<p><bold><italic>Conclusions:</italic></bold> Our study highlights a new role of GS in modulating immune response in microglia, providing insights into the pathogenic mechanisms associated with inflammation and new strategies of therapeutic intervention. <italic>Antioxid. Redox Signal.</italic> 26, 351–363.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title><bold>Keywords:</bold> </title>
<kwd>glutamine synthetase</kwd>
<kwd>glutamine</kwd>
<kwd>microglia</kwd>
<kwd>neuroinflammation</kwd>
<kwd>insulin resistance</kwd>
</kwd-group>
<counts>
<fig-count count="6"></fig-count>
<ref-count count="77"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>